Pacira BioSciences, Return On Equity vs. Current Valuation
| PCRX Stock | USD 16.64 0.14 0.83% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.04821693 | Current Value 0.0506 | Quarterly Volatility 1.46334068 |
For Pacira BioSciences, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pacira BioSciences, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pacira BioSciences, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pacira BioSciences,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pacira BioSciences, over time as well as its relative position and ranking within its peers.
Pacira |
Pacira BioSciences,'s Revenue Breakdown by Earning Segment
Check out Your Equity Center.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira BioSciences,. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira BioSciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (1.98) | Revenue Per Share 15.006 | Quarterly Revenue Growth 0.028 | Return On Assets 0.0417 |
The market value of Pacira BioSciences, is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira BioSciences,'s value that differs from its market value or its book value, called intrinsic value, which is Pacira BioSciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira BioSciences,'s market value can be influenced by many factors that don't directly affect Pacira BioSciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira BioSciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira BioSciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira BioSciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pacira BioSciences, Current Valuation vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pacira BioSciences,'s current stock value. Our valuation model uses many indicators to compare Pacira BioSciences, value to that of its competitors to determine the firm's financial worth. Pacira BioSciences, is rated below average in return on equity category among its peers. It is rated below average in current valuation category among its peers . At this time, Pacira BioSciences,'s Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pacira BioSciences,'s earnings, one of the primary drivers of an investment's value.Pacira Current Valuation vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Pacira BioSciences, |
| = | -0.11 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Pacira BioSciences, |
| = | 958.94 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Pacira Current Valuation vs Competition
Pacira BioSciences, is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 39.58 Billion. Pacira BioSciences, holds roughly 958.94 Million in current valuation claiming about 2.42% of equities under Health Care industry.
Pacira BioSciences, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pacira BioSciences,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pacira BioSciences, will eventually generate negative long term returns. The profitability progress is the general direction of Pacira BioSciences,'s change in net profit over the period of time. It can combine multiple indicators of Pacira BioSciences,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 247 K | 259.4 K | |
| Operating Income | 87.7 M | 92.1 M | |
| Income Before Tax | 61.7 M | 64.8 M | |
| Total Other Income Expense Net | -26 M | -24.7 M | |
| Net Income | 42 M | 44.1 M | |
| Income Tax Expense | 19.7 M | 20.7 M | |
| Net Income From Continuing Ops | 7 M | 7.3 M | |
| Non Operating Income Net Other | -2 M | -1.9 M | |
| Net Income Applicable To Common Shares | 18.3 M | 19.2 M | |
| Interest Income | 10.8 M | 5.8 M | |
| Net Interest Income | -17.2 M | -18 M | |
| Change To Netincome | 66.2 M | 69.5 M | |
| Net Income Per Share | 0.91 | 0.95 | |
| Income Quality | 3.69 | 3.87 | |
| Net Income Per E B T | 0.68 | 1.17 |
Pacira Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pacira BioSciences,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pacira BioSciences, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pacira BioSciences,'s important profitability drivers and their relationship over time.
Use Pacira BioSciences, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pacira BioSciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will appreciate offsetting losses from the drop in the long position's value.Pacira BioSciences, Pair Trading
Pacira BioSciences, Pair Trading Analysis
The ability to find closely correlated positions to Pacira BioSciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pacira BioSciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pacira BioSciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pacira BioSciences, to buy it.
The correlation of Pacira BioSciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pacira BioSciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pacira BioSciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pacira BioSciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Pacira BioSciences, position
In addition to having Pacira BioSciences, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.